Literature DB >> 15463395

The development and spread of drug-resistant malaria.

W H Wernsdorfer1.   

Abstract

Resistance of Plasmodium falciparum to chloroquine has emerged in the late 1950s and has now conquered the large majority of areas where this species is endemic. Resistance to alternative drugs has already occurred in several parts of the world and has become a particularly serious problem in Thailand. Emergence and spread of resistance are the result of interactions between parasite, humans, vector and drugs, enhanced by particular ecological features. The control of malaria transmission by means other than drugs would probably curb the propagation of resistance but current health care policies offer only limited prospects for the reactivation or implementation of systematic malaria control before the potential of the affordable antimalarials has been exhausted. In this article, Walther Wernsdorfer considers the epidemiological factors associated with the development and spread of drug-resistant malaria.

Entities:  

Year:  1991        PMID: 15463395     DOI: 10.1016/0169-4758(91)90262-m

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  31 in total

1.  Pfmdr1 alleles and response to ultralow-dose mefloquine treatment in Gabonese patients.

Authors:  Denise P Mawili-Mboumba; Jürgen F J Kun; Bertrand Lell; Peter G Kremsner; Francine Ntoumi
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron.

Authors:  B Pradines; C Rogier; T Fusai; J Mosnier; W Daries; E Barret; D Parzy
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 3.  The role of plant-derived drugs and herbal medicines in healthcare.

Authors:  P A De Smet
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

4.  Survival probability of drug resistant mutants in malaria parasites.

Authors:  M J Mackinnon
Journal:  Proc Biol Sci       Date:  1997-01-22       Impact factor: 5.349

5.  Desbutyl-benflumetol, a novel antimalarial compound: in vitro activity in fresh isolates of Plasmodium falciparum from Thailand.

Authors:  H Noedl; T Allmendinger; S Prajakwong; G Wernsdorfer; W H Wernsdorfer
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

6.  In vivo activity of ajoene against rodent malaria.

Authors:  H A Perez; M De la Rosa; R Apitz
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

7.  Enhancement of drug susceptibility in Plasmodium falciparum in vitro and Plasmodium berghei in vivo by mixed-function oxidase inhibitors.

Authors:  A M Ndifor; R E Howells; P G Bray; J L Ngu; S A Ward
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

8.  Multinormal in vitro distribution model suitable for the distribution of Plasmodium falciparum chemosusceptibility to doxycycline.

Authors:  Sébastien Briolant; Meili Baragatti; Philippe Parola; Fabrice Simon; Adama Tall; Cheikh Sokhna; Philippe Hovette; Modeste Mabika Mamfoumbi; Jean-Louis Koeck; Jean Delmont; André Spiegel; Jacky Castello; Jean Pierre Gardair; Jean Francois Trape; Maryvonne Kombila; Philippe Minodier; Thierry Fusai; Christophe Rogier; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2008-12-01       Impact factor: 5.191

9.  The contribution of the enzymes CYP2D6 and CYP2C19 in the demethylation of artemether in healthy subjects.

Authors:  M A van Agtmael; C A Van Der Graaf; T K Dien; R P Koopmans; C J van Boxtel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jul-Sep       Impact factor: 2.441

Review 10.  Global change and human vulnerability to vector-borne diseases.

Authors:  Robert W Sutherst
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.